Document is current

Any future updates will be listed below

Correction to: Phase I study of the anti‑TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors

Crossref DOI link: https://doi.org/10.1007/s00280-024-04645-9

Published Online: 2024-03-31

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark